Opportunity assessment: high. Nvidia is preparing to buy up to $10 billion of Anthropic stock when the Claude maker goes public, according to The Information. The report landed this week, and it puts a hard number on something the industry has been assuming for months: Nvidia intends to be a cornerstone shareholder in the second-biggest AI lab on the planet.
The Information’s report is short on structure and timing. What it does say is the size. Ten billion dollars. If that holds, it would be one of the largest anchor commitments to a single IPO on record.
What we know
- Nvidia may commit up to $10 billion to Anthropic’s IPO, as detailed in The Information.
- This is not Nvidia’s first Anthropic check. In November 2025, Nvidia and Microsoft announced a package where Nvidia would invest up to $10 billion and Microsoft up to $5 billion, tied to Anthropic buying roughly $30 billion of Azure compute and up to a gigawatt of Nvidia hardware.
- Anthropic has been reported to be laying IPO groundwork since late 2025, including hiring outside counsel. A public listing has looked like a 2026 or 2027 event.
- The Information doesn’t specify whether this is fresh money on top of the November commitment, or the same commitment restructured as an IPO purchase. That’s the open question.
Why this matters
Here’s my read. Nvidia isn’t buying Anthropic stock because it needs the upside. It’s buying a customer’s loyalty at the exact moment that customer gains the freedom to shop around.
Anthropic runs on three chip suppliers: Nvidia GPUs, Google TPUs, and Amazon’s Trainium. Google and Amazon are both major Anthropic investors, and both have spent the last two years pushing Anthropic toward their own silicon. A public Anthropic with a war chest of IPO cash could easily double down on TPUs or Trainium. A $10 billion Nvidia stake makes that conversation more complicated.
The pattern is familiar. Nvidia has already committed capital to OpenAI, xAI, Mistral, CoreWeave, and a long list of smaller labs. Critics call it circular financing: Nvidia funds the labs, the labs buy Nvidia chips, everyone’s revenue looks great. Supporters call it demand insurance. Both are right.
Tactical points for practitioners
- Compute pricing. Anthropic locked into Nvidia hardware means Claude’s inference costs track Nvidia’s roadmap, not Google’s or Amazon’s. If you’re building on Claude, Nvidia’s Rubin pricing now matters to your margins.
- IPO scale. Anthropic’s last reported private valuation sat well above $300 billion. A $10 billion anchor suggests an offering large enough to absorb it without Nvidia owning a controlling slice.
- Sequencing. OpenAI’s leadership has been publicly cooling on a 2026 listing. If Anthropic moves first, it sets the public-market benchmark for every frontier lab that follows.
- Regulatory exposure. A chip monopolist taking a multi-billion-dollar position in a top model maker is exactly the kind of deal antitrust regulators in the US and EU have been circling. Expect scrutiny.
What comes next
Watch for three signals. First, an S-1 filing, which would confirm the IPO timeline and disclose Nvidia’s existing stake. Second, any language about compute commitments attached to the investment. The November deal came bundled with hardware purchases, and this one probably will too. Third, a response from Google and Amazon. Neither will sit quietly while Nvidia buys a bigger seat at a table they helped build.
What stands out here is the shift in leverage. Two years ago, labs needed Nvidia’s chips and Nvidia’s blessing. Now Nvidia needs the labs to keep choosing it. Ten billion dollars is what that insurance costs.
The Information has the original reporting, and we’ll update as the IPO structure firms up.